TAKE LIMITED (NSE:TAKE)
21.28
-1.12 (-5.00%)
Jul 14, 2026, 3:30 PM IST
TAKE LIMITED Revenue
In the fiscal year ending March 31, 2026, TAKE LIMITED had annual revenue of 541.85M INR. TAKE LIMITED had revenue of 541.85M in the quarter ending March 31, 2026.
Revenue
541.85M
Revenue Growth
n/a
P/S Ratio
5.87
Revenue / Employee
270.93M
Employees
2
Market Cap
3.18B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 541.85M | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | 36.02M | -1.85B | -98.09% |
| Mar 31, 2023 | 1.89B | -4.64B | -71.03% |
| Mar 31, 2022 | 6.53B | -1.21B | -15.68% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 584.62B |
| Cipla | 278.28B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 105.60B |
| Valiant Laboratories | 2.37B |
| Infinium Pharmachem | 1.90B |
| Nureca | 1.47B |
| Lyka Labs | 1.28B |